Overview and clinical application of linezolid

Linezolid is a syntheticOxazolidinone antibiotics, mainly used to treat serious infections caused by Gram-positive bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), etc. Its mechanism of action is by inhibiting bacterial protein synthesis, with a unique antibacterial spectrum and good tissue penetration. This article will start fromPharmacological effects, indications, usage and dosage, adverse reactions and manufacturerIt will be expanded from other angles, focusing on analyzing its clinical value in anti-infectious treatment. The secondary content involves comparison with other antibiotics and medication precautions for special groups.

Pharmacological effects and antibacterial spectrum

Linezolid binds to the 50S site of the bacterial 23S ribosomal subunit, preventing the formation of the 70S initiation complex, therebyblock protein synthesis. It has significant antibacterial activity against Gram-positive bacteria (such as Staphylococcus aureus, Streptococcus aureus, and Enterococcus aureus), and is especially effective against MRSA and VRE. Compared with vancomycin or teicoplanin, linezolid has the advantages of high oral bioavailability (nearly 100%) and good tissue distribution (such as lungs, skin and soft tissues). However, it should be noted that it has no significant effect on Gram-negative bacteria, and clinical use must strictly follow the pathogenic test results.

Indications, usage and dosage

of linezolidMain indicationsIncluding hospital-acquired pneumonia, community-acquired pneumonia, complicated skin infections and bacteremia. The recommended dose for adults is 600 mg every 12 hours (orally or intravenously), and the course of treatment is usually 10-14 days. In children, dosage needs to be adjusted based on body weight. No dose adjustment is required in patients with renal impairment, but caution is required in patients with severely impaired liver function. Special attention should be paid to the fact that long-term use (more than 28 days) may increase the risk of bone marrow suppression, and regular blood routine monitoring is required.

Adverse reactions and drug interactions

Common adverse reactions includeGastrointestinal reactions (nausea, diarrhea), headache and thrombocytopenia. Rare but serious adverse reactions include lactic acidosis, peripheral neuropathy, and optic neuritis. Concomitant use of linezolid with serotonergic drugs (such as SSRI antidepressants) may increaseSerotonin syndromerisk. In addition, it is a reversible monoamine oxidase inhibitor (MAOI) and should be avoided in combination with tyramine-rich foods or sympathomimetic drugs.

Manufacturer and product information

Linezolid is produced byPfizerOriginal research, trade nameZyvox. There are many domestic generic drug companies producing them, such as Jiangsu Hansoh Pharmaceutical, Zhengda Tianqing, etc. The following table lists some manufacturers and product names:

As an important anti-MRSA/VRE drug, linezolid needs to be used rationally under the guidance of a doctor to avoid abuse leading to drug resistance. Its efficacy and safety have been verified by multiple clinical studies, but the individual risk-benefit ratio needs to be weighed.

Citing sources: 1. Pfizer Zyvox drug instructions; 2. "Chinese Expert Consensus on the Diagnosis and Treatment of Methicillin-Resistant Staphylococcus aureus Infections" (2020); 3. FDA drug database.